Cargando…
Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019657/ https://www.ncbi.nlm.nih.gov/pubmed/36928658 http://dx.doi.org/10.1371/journal.pone.0280200 |
_version_ | 1784908071138492416 |
---|---|
author | Kannukene, Angela Orrego, Carola Lember, Margus Uusküla, Anneli Põlluste, Kaja |
author_facet | Kannukene, Angela Orrego, Carola Lember, Margus Uusküla, Anneli Põlluste, Kaja |
author_sort | Kannukene, Angela |
collection | PubMed |
description | INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which has previously been modified to be used on various settings and translated into many languages. Multimorbidity complicates care and may increase the number of AEs patients experience. Currently there is no instrument designed to measure AEs in multimorbid patients. In Estonia, there is currently no validated instrument to measure the burden of AEs. AIMS: The aim of this study will be evaluating the characteristics and ocurrence of AEs in multimorbid patients in hospitalised internal medicine patients of Estonia, and describes the development of a trigger tool for this purpose. METHODS AND ANALYSIS: We will search for the evidence on measuring AEs in the population of multimorbid patients focusing on trigger tools, and synthesize the data. Data collection of the triggers from the literature will be followed by translating triggers from English to Estonian. An expert multidisciplinary panel will select the suitable triggers for this population. Trigger tool will be pre-tested to assess agreement among professionals and usability of the tool. Validation will be done using 90 medical records. A cross-sectional study in internal medicine departments of two Estonian tertiary care hospitals will be performed to identify the frequency and characteristics of AEs in 960 medical records. We will also provide preventability potential and influencing factors. DISSEMINATION: Results will be disseminated to healthcare providers and stakeholders at national and international conferences, and as a doctoral medical thesis. |
format | Online Article Text |
id | pubmed-10019657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100196572023-03-17 Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study Kannukene, Angela Orrego, Carola Lember, Margus Uusküla, Anneli Põlluste, Kaja PLoS One Study Protocol INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which has previously been modified to be used on various settings and translated into many languages. Multimorbidity complicates care and may increase the number of AEs patients experience. Currently there is no instrument designed to measure AEs in multimorbid patients. In Estonia, there is currently no validated instrument to measure the burden of AEs. AIMS: The aim of this study will be evaluating the characteristics and ocurrence of AEs in multimorbid patients in hospitalised internal medicine patients of Estonia, and describes the development of a trigger tool for this purpose. METHODS AND ANALYSIS: We will search for the evidence on measuring AEs in the population of multimorbid patients focusing on trigger tools, and synthesize the data. Data collection of the triggers from the literature will be followed by translating triggers from English to Estonian. An expert multidisciplinary panel will select the suitable triggers for this population. Trigger tool will be pre-tested to assess agreement among professionals and usability of the tool. Validation will be done using 90 medical records. A cross-sectional study in internal medicine departments of two Estonian tertiary care hospitals will be performed to identify the frequency and characteristics of AEs in 960 medical records. We will also provide preventability potential and influencing factors. DISSEMINATION: Results will be disseminated to healthcare providers and stakeholders at national and international conferences, and as a doctoral medical thesis. Public Library of Science 2023-03-16 /pmc/articles/PMC10019657/ /pubmed/36928658 http://dx.doi.org/10.1371/journal.pone.0280200 Text en © 2023 Kannukene et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Study Protocol Kannukene, Angela Orrego, Carola Lember, Margus Uusküla, Anneli Põlluste, Kaja Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title | Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title_full | Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title_fullStr | Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title_full_unstemmed | Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title_short | Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study |
title_sort | estonian adverse events study for multimorbid patients using estonian trigger tool (mupett—multimorbid patients—estonian trigger tool). development of estonian trigger tool for multimorbid patients. a study protocol for mixed-methods study |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019657/ https://www.ncbi.nlm.nih.gov/pubmed/36928658 http://dx.doi.org/10.1371/journal.pone.0280200 |
work_keys_str_mv | AT kannukeneangela estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy AT orregocarola estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy AT lembermargus estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy AT uuskulaanneli estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy AT pollustekaja estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy |